About Ensoma
Ensoma is a company based in Boston (United States) founded in 2019.. Ensoma has raised $205 million across 3 funding rounds from investors including ARE, Mirae Asset and Takeda Pharmaceuticals. The company has 52 employees as of December 31, 2021. Ensoma has completed 1 acquisition, including Twelve Bio. Ensoma offers products and services including HSC Engineering Platform and In Vivo Treatments. Ensoma operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Boston, United States
- Employees 52 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ensoma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$205 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series B
May 16, 2023
-
Investors
ARE
& 19 more
-
Employee Count
52
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ensoma
Ensoma offers a comprehensive portfolio of products and services, including HSC Engineering Platform and In Vivo Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for in vivo engineering of stem cells to treat diseases.
One-time therapies targeting genetic and immune disorders.
Unlock access to complete
Unlock access to complete
Funding Insights of Ensoma
Ensoma has successfully raised a total of $205M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $50.0M
-
First Round
First Round
(11 Feb 2021)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series B - Ensoma | Valuation |
investors |
|
| Jan, 2023 | Amount | Series B - Ensoma | Valuation | Arix Bioscience , 5AM Ventures | |
| Feb, 2021 | Amount | Series A - Ensoma | Valuation | 5AM Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ensoma
Ensoma has secured backing from 20 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Mirae Asset and Takeda Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital firm focused on biotechnology innovations.
|
Founded Year | Domain | Location | |
|
Delos Capital is engaged in private equity and financial advisory services.
|
Founded Year | Domain | Location | |
|
Investments in healthcare companies are made by SymBiosis.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ensoma
Ensoma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Twelve Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRISPR-Cas12a technology is applied to develop diagnostics and therapeutics.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Ensoma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ensoma Comparisons
Competitors of Ensoma
Ensoma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ensoma
When was Ensoma founded?
Ensoma was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is Ensoma located?
Ensoma is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Ensoma a funded company?
Ensoma is a funded company, having raised a total of $205M across 3 funding rounds to date. The company's 1st funding round was a Series A of $70M, raised on Feb 11, 2021.
How many employees does Ensoma have?
As of Dec 31, 2021, the latest employee count at Ensoma is 52.
What does Ensoma do?
Ensoma was founded in 2019 and is based in Boston, United States. Operations focus on biotechnology, specifically in vivo modification of hematopoietic stem cells and other immune cells using engineered adenovirus vectors known as Engenious. These vectors enable delivery of genome modification technologies for treating myeloablative conditions through a single injection. Services target applications in T cells, B cells, and myeloid cells within the therapeutic sector.
Who are the top competitors of Ensoma?
Ensoma's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Ensoma offer?
Ensoma offers HSC Engineering Platform and In Vivo Treatments.
How many acquisitions has Ensoma made?
Ensoma has made 1 acquisition, including Twelve Bio.
Who are Ensoma's investors?
Ensoma has 20 investors. Key investors include ARE, Mirae Asset, Takeda Pharmaceuticals, Kite Pharma, and Fred Hutch.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.